DNA repair and cancer stem-like cells – Potential partners in glioma drug resistance?

This publication has 84 references indexed in Scilit:

• CD133+ and CD133− Glioblastoma-Derived Cancer Stem Cells Show Differential Growth Characteristics and Molecular Profiles
  Cancer Research, 2007
• Loss of the Mismatch Repair Protein MSH6 in Human Glioblastomas Is Associated with Tumor Progression during Temozolomide Treatment
  Clinical Cancer Research, 2007
• HEDGEHOG-GLI1 Signaling Regulates Human Glioma Growth, Cancer Stem Cell Self-Renewal, and Tumorigenicity
  Current Biology, 2007
• Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
  Nature, 2006
• ATR Kinase Activation Mediated by MutSα and MutLα in Response to Cytotoxic O6-Methylguanine Adducts
  Molecular Cell, 2006
• The multifaceted mismatch-repair system
  Nature Reviews Molecular Cell Biology, 2006
• Tumour stem cells and drug resistance
  Nature Reviews Cancer, 2005
• Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
  New England Journal of Medicine, 2005
• The Ways of PARP
  Cell, 2004
• Prospective identification of tumorigenic breast cancer cells
  Proceedings of the National Academy of Sciences, 2003